>AT3G21250.1 |  ATMRP6 ATPase coupled to transmembrane movement of substances 
MSLLLLLCSWMNLRSSSAAAQDCSVTGLSDPLLTKNPRKESARLATAGFFSILSFSWMNP 
LLSLGFKKPLSPEDIPSVVPEDEAQLAYKKFSQAWDTLLGDESSTKERNLVFRAVVKVYF 
KENIFIAVFAFLRTFAVVSLPLMLYVFVDYANSDHRDLRNGFFNLACLVMLKLVESLTMR 
HWYFASRRSGMRIRSALMVAAYKKQLKLSSLGRKRHSSGEIVNYIAVDAYRMGEFLWWFH 
SGWSLSLQLLLSTAVLFGVVGAGAFPGLILLLLCGLLNLPFAKMLQNCQTQFMIAQDKRL 
RSTSEILNSMKVIKLQSWEDEFKKKIESCRDDEFTWLAKAQLTKAFGSFLYWMSPTIVSS 
VVFLGCALLKSAPLNASTIFTVLATLRVMSEPVKIIPDAISAIIQGNVSFQRLNNFLLDD 
ELKMDEIERSGLDASGTAVDIQVGNFGWEPETKIPTLRNIHLEIKHGQKVAVCGPVGAGK 
SSLLHAVLGEIPKVSGTVKVFGSIAYVSQTSWIQSGTIRDNILYGKPMESRRYNAAIKAC 
ALDKDMNGFGHGDLTEIGQRGINLSGGQKQRIQLARAVYADADVYLLDDPFSAVDAHTAG 
VLFHKCVEDSLKEKTVILVTHQVMEEGTITQSGKYEELLMMGTAFQQLVNAHNDAVTVLP 
LASNESLGDLRKEGKDREIRNMTVVEKIEEEIEKTDIPGVQLTQEEEKESGYVGMKPFLD 
YIGVSRGWCLLWSSVLGQVGFVVFQAASTYWLAFAIGIPKITNTMLIGVYSIISTLSAGF 
VYARAITTAHLGLKASKAFFSGFTNAVFKAPMLFFDSTPVGRILTRASSDLNVLDYDVPF 
AFIFVVAPAVELTAALLIMTYVTWQVIIIALLALAATKVVQDYYLASARELIRINGTTKA 
PVMNYAAETSLGVVTIRAFGTAERFFKNYLNLVDADAVLFFLSNAAMEWVILRIETLQNV 
TLFTCALLLILIPKGYIAPGLVGLSLSYALTLTQTQVFLTRWYCTLSNSIISVERIKQYM 
NIPEEPPAIIDDKRPPSSWPSNGTIHLQELKIRYRPNAPLVLKGISCTFREGTRVGVVGR 
TGSGKSTLISALFRLVEPASGCILIDGIDISKIGLKDLRMKLSIIPQEPTLFRGCIRTNL 
DPLGVYSDDEIWKALEKCQLKTTISNLPNKLDSSVSDEGENWSVGQRQLFCLGRVLLKRN 
KILVLDEATASIDSATDAIIQRIIREEFADCTVITVAHRVPTVIDSDMVMVLSFGDLVEY 
NEPSKLMETDSYFSKLVAEYWASCRGNSSQNLQL*
>AT5G17680.1 |  disease resistance protein (TIR-NBS-LRR class) putative 
MASLPSSSSSSSSTVWKTDVFVSFRGEDVRKTFVSHLFCEFDRMGIKAFRDDLDLQRGKS 
ISPELIDAIKGSRFAIVVVSRNYAASSWCLDELLKIMECNKDTIVPIFYEVDPSDVRRQR 
GSFGEDVESHSDKEKVGKWKEALKKLAAISGEDSRNWDDSKLIKKIVKDISDKLVSTSWD 
DSKGLIGMSSHMDFLQSMISIVDKDVRMLGIWGMGGVGKTTIAKYLYNQLSGQFQVHCFM 
ENVKEVCNRYGVRRLQVEFLCRMFQERDKEAWSSVSCCNIIKERFRHKMVFIVLDDVDRS 
EQLNELVKETGWFGPGSRIIVTTRDRHLLLSHGINLVYKVKCLPKKEALQLFCNYAFREE 
IILPHGFEELSVQAVNYASGLPLALRVLGSFLYRRSQIEWESTLARLKTYPHSDIMEVLR 
VSYDGLDEQEKAIFLYISCFYNMKQVDYVRKLLDLCGYAAEIGITILTEKSLIVESNGCV 
KIHDLLEQMGRELVRQQAVNNPAQRLLLWDPEDICHLLSENSGTQLVEGISLNLSEISEV 
FASDRAFEGLSNLKLLNFYDLSFDGETRVHLPNGLSYLPRKLRYLRWDGYPLKTMPSRFF 
PEFLVELCMSNSNLEKLWDGIQPLRNLKKMDLSRCKYLVEVPDLSKATNLEELNLSYCQS 
LVEVTPSIKNLKGLSCFYLTNCIQLKDIPIGIILKSLETVGMSGCSSLKHFPEISWNTRR 
LYLSSTKIEELPSSISRLSCLVKLDMSDCQRLRTLPSYLGHLVSLKSLNLDGCRRLENLP 
DTLQNLTSLETLEVSGCLNVNEFPRVSTSIEVLRISETSIEEIPARICNLSQLRSLDISE 
NKRLASLPVSISELRSLEKLKLSGCSVLESFPLEICQTMSCLRWFDLDRTSIKELPENIG 
NLVALEVLQASRTVIRRAPWSIARLTRLQVLAIGNSFFTPEGLLHSLCPPLSRFDDLRAL 
SLSNMNMTEIPNSIGNLWNLLELDLSGNNFEFIPASIKRLTRLNRLNLNNCQRLQALPDE 
LPRGLLYIYIHSCTSLVSISGCFNQYCLRKLVASNCYKLDQAAQILIHRNLKLESAKPEH 
SYFPGSDIPTCFNHQVMGPSLNIQLPQSESSSDILGFSACIMIGVDGQYPMNNLKIHCSC 
ILKDADACELVVMDEVWYPDPKAFTNMYFGSDHLLLFSRTCTSMEAYSEALFEFSVENTE 
GDSFSPLGEVKKCAVHLISLKDMMQEFSNDSDKIQSSDLDLPKAFDDARILKRRAYETEF 
LHKEQLNPKRIKFLPVPLARERHSKLHQRNVIRK*
>AT5G60930.1 |  chromosome-associated kinesin putative 
MESTECVRVAVNIRPLITPELLNGCTDCITVAPKEPQVHIGSHTFTYDFVYGNGGYPCSE 
IYNHCVAPLVDALFKGYNATVLAYGQTGSGKTYTMGTNYSGDCTNGGVIPNVMEDIFRRV 
ETTKDSSELLIRVSFIEIFKEEVFDLLDSNSSALLKNDSGVQAKHTALSRAPIQIRETAS 
GGITLAGVTEAEVKTKEEMGSFLARGSLSRATGSTNMNSQSSRSHAIFTITLEQKKIAGG 
SCTTTEDGGEDILCAKLHLVDLAGSERAKRTGADGMRLKEGIHINKGLLALGNVISALGD 
EKKRKEGGHVPYRDSKLTRLLQDSLGGNSKTVMIACVSPADTNAEETLNTLKYANRARNI 
QNKAVINRDPATAQMQRMRSQIEQLQTELLFYRGDSGAFDELQILKHKISLLEASNRELH 
NELQERRVASEHFSKRAYDAQVEKDKLIMIIESVRNGKSLDEIESCQNEDVGLVNKYVSK 
IQELEGELLHIKNLKKTSNHQYSDDSYDVGPRSNNVLFPSSNESSDCEDKVMDVTDELEF 
QEKEIEHCSLQEKLDMELKELDKRLEEKEAEMKRFSSGGTSVLKQHYEKKVYDLEQEKRA 
LQREIEGLRHNLASIPSGPGDGAQKLKEEYVQKLNTLETQVSVLKKKQDAQAQLMRQKQK 
SDDAAIKLQDEIHRIKSQKVQLQQKIKQESEQFRAWKASREKEVMQLKKEGRRNEYEMHK 
LMALNQKQKLVLQRKTEEASQVTKRLKELLDNRKASSRETLSGANGPGTQALMQAIEHEI 
EVTVRVHEVRSEYERQTEERARMAKEVARLREENELLKNAKISVHGDTMSPGARNSRIFA 
LENMLATSSSTLVSMASQLSEAEERERVFGGRGRWNQVRTLGDAKSIMNYLFNLASTARC 
LARDKEADCREKDVLIRDLKEKIVKFSSYVRYMEIQKADLVHQVKAQTSAMKKLSADENL 
KNEHSMKKQETRNSTIVLEDMDTSDSEASDHEREDPDLDDEWKPEHESERESEQESVIKL 
NRKRNFKVGRRRSSVVMRRSYEENSETPSDDAVKSDVCCCTCSKSSSCKTMKCQCRATKG 
SCGPSCGCSSVKCSNRNADGKENNSISESEALENGENSQESDEKDKGQQQQVLASRGAML 
LQNALADKPEEETNDDGGTRRRRKPLSDIGNTTGKSNVPRPSQRKKWKKTVLQLVPVGPP 
ALPPTHTNTHLIPEANSVTVDSDTARMPENSDSGESNSIKLKLPRAMRAIRVGQVEVELQ 
MKRRTTLVGSKEETSLEVPVVNFLRQIQLLKFEV*
>AT5G11250.1 |  disease resistance protein (TIR-NBS-LRR class) putative 
MASSFFLTTVAAAIGFFTLLRKLRFHHDNKEKKSTSLSPSSSPSSLSPSSVPPPSSSCIW 
THQVFPSFSGEDVRRDFLSHIQMEFQRMGITPFVDNEIKRGESIGPELLRAIRGSKIAII 
LLSRNYASSKWCLDELVEIMKCREEYGQTVMAIFYKVDPSDVKNLTGDFGKVFRKTCAGK 
PKKDIGRWRQAWEKVATVAGYHSINWDNEAAMIKKIATDISNILINSTPSRDFDGLVGMR 
AHLEKMKPLLCLDTDEVRIIGIWGPPGIGKTTIARVVYNQLSHSFQLSVFMENIKANYTR 
PTGSDDYSAKLQLQQMFMSQITKQKDIEIPHLGVAQDRLKDKKVLVVLDGVNQSVQLDAM 
AKEAWWFGPGSRIIITTQDQKLFRAHGINHIYKVDFPPTEEALQIFCMYAFGQNSPKDGF 
QNLAWKVINLAGNLPLGLRIMGSYFRGMSREEWKKSLPRLESSLDADIQSILKFSYDALD 
DEDKNLFLHIACFFNGKEIKILEEHLAKKFVEVRQRLNVLAEKSLISFSNWGTIEMHKLL 
AKLGGEIVRNQSIHEPGQRQFLFDGEEICDVLNGDAAGSKSVIGIDFHYIIEEEFDMNER 
VFEGMSNLQFLRFDCDHDTLQLSRGLSYLSRKLQLLDWIYFPMTCLPSTVNVEFLIELNL 
THSKLDMLWEGVKPLHNLRQMDLSYSVNLKELPDLSTAINLRKLILSNCSSLIKLPSCIG 
NAINLEDLDLNGCSSLVELPSFGDAINLQKLLLRYCSNLVELPSSIGNAINLRELDLYYC 
SSLIRLPSSIGNAINLLILDLNGCSNLLELPSSIGNAINLQKLDLRRCAKLLELPSSIGN 
AINLQNLLLDDCSSLLELPSSIGNATNLVYMNLSNCSNLVELPLSIGNLQKLQELILKGC 
SKLEDLPININLESLDILVLNDCSMLKRFPEISTNVRALYLCGTAIEEVPLSIRSWPRLD 
ELLMSYFDNLVEFPHVLDIITNLDLSGKEIQEVPPLIKRISRLQTLILKGYRKVVSLPQI 
PDSLKWIDAEDCESLERLDCSFHNPEITLFFGKCFKLNQEARDLIIQTPTKQAVLPGREV 
PAYFTHRASGGSLTIKLNERPLPTSMRYKACILLVRIGDYGAHDRDKWLHVAFGVRSTTL 
GHIIYSGLTEHLYTFEIEEKVTSSELVFEFKVENGNHWKIGECGLRQLS*